Legislation to spur development of treatments for pediatric and rare diseases easily cleared a US House committee on 18 September, boosting chances for inclusion in an end-of-year omnibus package.
An amended version of the Give Kids A Chance Act of 2024 (H.R. 3433) advanced out of the House...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?